<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T21:18:32Z</responseDate>
  <request identifier="oai:figshare.com:article/34034650" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34034650</identifier>
        <datestamp>2026-09-30T17:26:44Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Segmentation analysis for immunocytochemistry images from &lt;i&gt;in vitro&lt;/i&gt; models of PD.&lt;/p&gt;</dc:title>
          <dc:creator>Noelle Callizot (5660677)</dc:creator>
          <dc:creator>Georgia Culley (15148575)</dc:creator>
          <dc:creator>Grace Flower (25145065)</dc:creator>
          <dc:creator>Laura Rouvière (16400955)</dc:creator>
          <dc:creator>Véronique De Conto (25145068)</dc:creator>
          <dc:creator>Alexandre Wojcinski (6340172)</dc:creator>
          <dc:creator>Catherine Botto (25145071)</dc:creator>
          <dc:creator>Cecilia Estrella (1618609)</dc:creator>
          <dc:creator>Alexandre Henriques (359791)</dc:creator>
          <dc:creator>Philippe Verwaerde (1618624)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>promising therapeutic approach</dc:subject>
          <dc:subject>lewy bodies ).</dc:subject>
          <dc:subject>several lysosomal enzymes</dc:subject>
          <dc:subject>restoring lysosomal homeostasis</dc:subject>
          <dc:subject>lysosomal availability depend</dc:subject>
          <dc:subject>like models (&lt;</dc:subject>
          <dc:subject>parkinson &amp;# 8217</dc:subject>
          <dc:subject>maintaining lysosomal function</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>neuroprotective effects involve</dc:subject>
          <dc:subject>several parkinson ’</dc:subject>
          <dc:subject>lysosomal function</dc:subject>
          <dc:subject>neuroprotective effects</dc:subject>
          <dc:subject>lysosomal system</dc:subject>
          <dc:subject>lysosomal dysfunction</dc:subject>
          <dc:subject>parkinson ’</dc:subject>
          <dc:subject>neuroprotective action</dc:subject>
          <dc:subject>disease models</dc:subject>
          <dc:subject>vivo &lt;/</dc:subject>
          <dc:subject>vitro &lt;/</dc:subject>
          <dc:subject>ultimately supporting</dc:subject>
          <dc:subject>prone proteins</dc:subject>
          <dc:subject>pathohistological hallmarks</dc:subject>
          <dc:subject>mitochondrial injury</dc:subject>
          <dc:subject>genetic connections</dc:subject>
          <dc:subject>endoplasmic reticulum</dc:subject>
          <dc:subject>dopaminergic neurons</dc:subject>
          <dc:subject>direct link</dc:subject>
          <dc:subject>clinical development</dc:subject>
          <dc:description>&lt;p&gt;Cell segmentation to separate the nuclear and cytoplasmic compartments which were then used to assess the area of markers, e.g., within the cytoplasmic compartment (A). Neurite segmentation in TH(+) neurons (red), observed in green (B). PSD95(+) puncta (green) in TH(+) neurites (red) (C).&lt;/p&gt; &lt;p&gt;(TIF)&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:26:42Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0359269.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Segmentation_analysis_for_immunocytochemistry_images_from_i_in_vitro_i_models_of_PD_p_/34034650</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
